We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
Cap. Flow
+$404M
Cap. Flow %
6.55%
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313

Top Buys

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$197M
2
AGN
Allergan plc
AGN
+$135M
3
BHC icon
Bausch Health
BHC
+$129M
4
CVS icon
CVS Health
CVS
+$107M
5
MCK icon
McKesson
MCK
+$94.3M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$286M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$225M
3
GILD icon
Gilead Sciences
GILD
+$86.1M
4
PRGO icon
Perrigo
PRGO
+$79.4M
5
CAH icon
Cardinal Health
CAH
+$74.8M

Sector Composition

Rank Sector Weight
1 Healthcare 53.16%
2 Consumer Discretionary 5.06%
3 Energy 4.01%
4 Utilities 3.23%
5 Financials 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$441M 7.14%
2,143,563
+681,102
+47% +$135M
ENDP
2
DELISTED
Endo International plc
ENDP
$243M 3.94%
3,542,774
+2,775,755
+362% +$197M
BHC icon
3
Bausch Health
BHC
$2.57B
$226M 3.65%
1,711,727
+944,757
+123% +$129M
CAH icon
4
Cardinal Health
CAH
$53.9B
$223M 3.62%
3,191,347
-1,075,821
-25% -$74.8M
BKD icon
5
Brookdale Senior Living
BKD
$3.49B
$190M 3.07%
5,661,100
+1,638,205
+41% +$49.6M
SLXP
6
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$183M 2.96%
1,764,566
+724,497
+70% +$74.2M
MCK icon
7
McKesson
MCK
$100B
$126M 2.03%
711,693
+539,368
+313% +$94.3M
CVS icon
8
CVS Health
CVS
$133B
$122M 1.98%
1,632,853
+1,520,545
+1,354% +$107M
TEVA icon
9
Teva Pharmaceuticals
TEVA
$40.8B
$106M 1.72%
2,012,493
+1,951,949
+3,224% +$90.2M
REGN icon
10
Regeneron Pharmaceuticals
REGN
$78.5B
$86M 1.39%
+286,563
New +$88.3M
CLVS
11
DELISTED
Clovis Oncology, Inc.
CLVS
$80.3M 1.3%
1,159,623
+598,439
+107% +$43.9M
PCRX icon
12
Pacira BioSciences
PCRX
$1.04B
$72.1M 1.17%
1,030,000
-110,000
-10% -$7.48M
MET icon
13
MetLife
MET
$61.9B
$69.5M 1.13%
1,477,160
+1,466,590
+13,875% +$67.4M
AMRI
14
DELISTED
Albany Molecular Research Inc
AMRI
$58.6M 0.95%
3,150,000
– –
GRFS
15
Grifois
GRFS
$5.36B
$53.5M 0.87%
2,588,758
-567,866
-18% -$11.3M
DGX icon
16
CALL
Quest Diagnostics
DGX
$25.7B
$52M 0.84%
897,600
+896,574
+87,385% +$48.1M
SPY icon
17
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$50.9M 0.82%
271,900
+270,900
+27,090% +$49.7M
PRGO icon
18
Perrigo
PRGO
$1.4B
$46.6M 0.75%
301,409
-502,845
-63% -$79.4M
WMGI
19
DELISTED
Wright Medical Group Inc
WMGI
$45.5M 0.74%
1,463,642
+602,755
+70% +$19M
HR icon
20
Healthcare Realty
HR
$7.28B
$44.2M 0.72%
1,941,290
+54,316
+3% +$1.18M
ELOS
21
DELISTED
Syneron Medical Ltd
ELOS
$42.5M 0.69%
3,410,000
+5,000
+0.1% +$59.2K
MED icon
22
Medifast
MED
$109M
$39.3M 0.64%
1,350,000
– –
PPL
23
PPL Corp
PPL
$26.5B
$39M 0.63%
1,264,740
+467,358
+59% +$13.6M
AMAG
24
DELISTED
AMAG Pharmaceuticals
AMAG
$38.7M 0.63%
+2,000,200
New +$42.5M
ISRG icon
25
Intuitive Surgical
ISRG
$127B
$38.1M 0.62%
782,865
+474,966
+154% +$22.4M
1
2 3 4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.

  • Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
  • Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
  • Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
  • Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
  • Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
  • Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
  • Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.

Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.